Clin2
NCT07865676Possibly a fitRecruiting

Stem cell injection for age-related muscle loss

Sarcopenia

Part of Brain & nervous system clinical trials.

This trial tests an injection of donor bone marrow stem cells to see if it can improve muscle strength and function in people with age-related muscle loss, called sarcopenia. It may help those who cannot do regular exercise training.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
30 people
Ages
50 years to 85 years
Study type
Interventional

Who can take part

  • You are 50 to 84 years old
  • You have been diagnosed with sarcopenia (age-related muscle loss)
  • You weigh more than 35 kg (about 77 lbs)
  • You are unable or unwilling to do regular resistance exercise
  • You agree not to father a child (if male) or use effective birth control (if female of childbearing age)
  • You have no allergies to the stem cell product ingredients

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07808905Not yet recruiting· Phase 1/Phase 2
Stem cell treatment for age-related muscle loss

This study tests an experimental treatment called EN001, made from stem cells, to see if it can help improve muscle strength and function in older adults with sarcopenia. Participants will receive the treatment or a placebo, and all will follow a diet and exercise program.

Seoul
NCT07668258Not yet recruiting
Muscle stimulation therapy for age-related muscle loss

This trial tests whether a muscle-stimulation device (using mild electrical pulses) can help people with sarcopenia (age-related muscle loss) regain strength. You'll also do an exercise program, and the study aims to see if this combination improves mobility and function.

NCT07072195Recruiting· Phase 2
A study of AMC6156 for people with muscle loss

This trial tests an investigational drug called AMC6156 to see if it can help improve muscle mass and strength in older adults with sarcopenia (age-related muscle loss). Participants will also follow exercise and nutrition guidance.

Seongnam-si, Gyeonggi-do
NCT06736249Recruiting
Testing a new treatment for muscle loss in sarcopenia

This trial tests a new approach to treat sarcopenia (age-related muscle loss) by targeting a protein called HIF-1α. It compares older adults with sarcopenia to younger adults without it, all of whom are having hip or knee surgery.

Milan, Europe
NCT07049731Not yet recruiting
Protein powder and exercise for muscle health

This study tests whether a protein powder combined with resistance exercise can improve muscle and bone health in people with sarcopenia (age-related loss of muscle). It may help you become stronger and more mobile.

Beijing
NCT07692308Recruiting
Muscle health study for sarcopenia prevention and treatment

This study looks at muscle changes in people with or at risk for sarcopenia (age-related muscle loss). It aims to find better ways to detect and manage sarcopenia using simple tests like muscle strength and body composition measurements.

Milan, Mi

Hear when a new Sarcopenia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.